Thursday, December 19, 2019

McKesson - Legal Troubles

Pharmaceutical distributor McKesson (NYSE: MCK) remains in the spotlight for its role in the opioid epidemic. Earlier this month, McKesson agreed to settle a lawsuit with the state of West Virginia for $37 million. The lawsuit claimed that the company flooded the market with highly addictive narcotics and misled the public. This is just one of a multitude of settlements we expect McKesson to pay going forward. McKesson estimates opioid litigation alone will cost it $100 million in 2019 and $150 million per year starting in 2020. This litigation will only grow from here.

First posted on Facebook

All posts and charts are for educational and illustration purposes only

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.